美国食品和药物管理局计划禁止口服在感冒药中使用, The FDA plans to ban oral phenylephrine in cold medications due to its ineffectiveness.

美国食品和药物管理局建议禁止口服烯酸,这是非处方感冒药的常见成分,因为证据表明它对缓解鼻塞无效. The FDA has proposed banning oral phenylephrine, a common ingredient in over-the-counter cold medications, due to evidence showing it is ineffective for relieving nasal congestion. 该提案经过广泛的审查和公开评论后提出,有待作出最后决定。 This proposal follows extensive review and public comments, with a final decision pending. 如果颁布,制造商必须重新配制或去除含有口服苯丙胺的产品,尽管鼻涕喷雾形式仍然不受影响。 If enacted, manufacturers must reformulate or remove products containing oral phenylephrine, though nasal spray forms remain unaffected. 搬迁并非基于安全考虑。 The move is not based on safety concerns.